| Synthesis of di-and tripeptide analogues containing α-ketoamide as a new core structure for inhibition of HIV-1 protease MM Sheha, NM Mahfouz, HY Hassan, AF Youssef, T Mimoto, Y Kiso European journal of medicinal chemistry 35 (10), 887-894, 2000 | 77 | 2000 |
| Biological and metabolic study of naproxen–propyphenazone mutual prodrug M Sheha, A Khedr, H Elsherief European journal of pharmaceutical sciences 17 (3), 121-130, 2002 | 56 | 2002 |
| Quantitative thin-layer chromatographic method of analysis of azithromycin in pure and capsule forms A Khedr, M Sheha Journal of chromatographic science 41 (1), 10-16, 2003 | 34 | 2003 |
| Enhanced delivery of γ-secretase inhibitor DAPT into the brain via an ascorbic acid mediated strategy G Quéléver, P Kachidian, C Melon, C Garino, Y Laras, N Pietrancosta, ... Organic & Biomolecular Chemistry 3 (13), 2450-2457, 2005 | 33 | 2005 |
| 1, 2‐dihydroisoquinoline‐N‐acetic acid derivatives as new carriers for specific brain delivery I: synthesis and estimation of oxidation kinetics using multivariate calibration … S Mahmoud, T Aboul‐Fadl, M Sheha, H Farag, AMI Mouhamed Archiv der Pharmazie: An International Journal Pharmaceutical and Medicinal …, 2003 | 30 | 2003 |
| Brain delivery of HIV protease inhibitors MM Sheha, NA El‐Koussi, HH Farag Archiv der Pharmazie: An International Journal Pharmaceutical and Medicinal …, 2003 | 29 | 2003 |
| New carrier for specific delivery of drugs to the brain M Sheha, A Al-Tayeb, H El-Sherief, H Farag Bioorganic & medicinal chemistry 11 (8), 1865-1872, 2003 | 28 | 2003 |
| Synthesis, antimicrobial activity and molecular modeling study of 3-(5-amino-(2H)-1, 2, 4-triazol-3-yl]-naphthyridinones as potential DNA-gyrase inhibitors NG Mohamed, MM Sheha, HY Hassan, LJM Abdel-Hafez, FA Omar Bioorganic Chemistry 81, 599-611, 2018 | 27 | 2018 |
| Substituted thiazolamide coupled to a redox delivery system: a new γ-secretase inhibitor with enhanced pharmacokinetic profile Y Laras, G Quéléver, C Garino, N Pietrancosta, M Sheha, F Bihel, ... Organic & Biomolecular Chemistry 3 (4), 612-618, 2005 | 27 | 2005 |
| Pharmacokinetic and ulcerogenic studies of naproxen prodrugs designed for specific brain delivery M Sheha Archives of pharmacal research 35, 523-530, 2012 | 24 | 2012 |
| Stress degradation studies on betahistine and development of a validated stability-indicating assay method A Khedr, M Sheha Journal of Chromatography B 869 (1-2), 111-117, 2008 | 23 | 2008 |
| Sensitive determination of trimetazidine in spiked human plasma by HPLC with fluorescence detection after pre-column derivatization with 9-fluorenylmethyl chloroformate A Khedr, MM Sheha, IA Darwish Journal of Chromatography B 856 (1-2), 337-342, 2007 | 23 | 2007 |
| Synthesis, Antibacterial Activity and Molecular Docking of Substituted Naphthyridines as Potential DNA Gyrase Inhibitors FA Omar, M Abelrasoul, MM Sheha, HY Hassan, YM Ibrahiem ChemistrySelect 3 (9), 2604-2612, 2018 | 16 | 2018 |
| 1, 2‐dihydroisoquinoline‐N‐acetic acid derivatives as new carriers for brain‐specific delivery II: delivery of phenethylamine as model drug S Mahmoud, M Sheha, T Aboul‐Fadl, H Farag Archiv der Pharmazie: An International Journal Pharmaceutical and Medicinal …, 2003 | 11 | 2003 |
| 1, 2‐dihydroisoquinoline‐N‐acetic acid derivatives as new carriers for brain‐specific delivery II: delivery of phenethylamine as model drug S Mahmoud, M Sheha, T Aboul‐Fadl, H Farag Archiv der Pharmazie: An International Journal Pharmaceutical and Medicinal …, 2003 | 11 | 2003 |
| Thiazolamide–Ascorbic Acid Conjugate: a γ-Secretase Inhibitor with Enhanced Blood–Brain Barrier Permeation Y Laras, M Sheha, N Pietrancosta, JL Kraus Australian journal of chemistry 60 (2), 128-132, 2007 | 9 | 2007 |
| Design, synthesis, and cytotoxicity evaluation of novel griseofulvin analogues with improved water solubility AK Hamdy, MM Sheha, AA Abdel-Hafez, SA Shouman International Journal of Medicinal Chemistry 2017, 2017 | 7 | 2017 |
| Design, synthesis, and modelling study of new 1, 2, 3‐triazole/chalcone hybrids with antiproliferative action as epidermal growth factor receptor inhibitors MTE Maghraby, OIA Salem, BGM Youssif, MM Sheha Chemical Biology & Drug Design 101 (3), 749-759, 2023 | 5 | 2023 |
| Amantadine amides prodrugs as hepatic delivery systems to enhance its activity against HCV T Aboul-Fadl, MM Sheha, AS El-Azab, HA Abdel-Aziz Dig J Nanomater Biostruct 6, 1675-1683, 2011 | 4 | 2011 |
| New 1, 2, 3-triazole/1, 2, 4-triazole hybrids as aromatase inhibitors: Design, synthesis, and apoptotic antiproliferative activity MTE Maghraby, T Mazyad Almutairi, S Bräse, OIA Salem, BGM Youssif, ... Molecules 28 (20), 7092, 2023 | 2 | 2023 |
